Add this topic to your myFT Digest for news straight to your inbox
Not only is the cost-benefit ratio unbeatable, but not to undertake this spending is to court disaster
Call for rapid detection comes as pharma groups criticise draft WHO treaty on how to avoid another health crisis
Cepi releases blueprint to move three times faster against a new virus than during Covid-19 pandemic
This is how the world can get faster and smarter in its ability to respond to outbreaks of new infectious diseases
Funding from Coalition for Epidemic Preparedness Innovations to ‘create critical tools’ to assess jabs
Warning against ‘cycles of panic and neglect’ as Covid-19 threat appears to fade
Switch in US company’s stance follows criticism over vaccine inequality in low- and middle-income nations
Omicron has exposed the weakness in current vaccines and revived interest in an all-protective ‘super jab’
Health officials are on the watch, and philanthropists’ funds are even at the ready, but the provenance of the next emergency remains uncertain
Philanthropist calls on governments to contribute billions to tackle future pathogens and increase vaccine supplies
Platform aims to match manufacturers with suppliers to address supply chain bottlenecks
A so-called multivalent vaccine might protect against all Covid-19 mutations and any future pathogen from the betacoronavirus family
International Edition